HBA Announces 2020 ACE Award Winners
Women’s leadership and mentoring initiatives garner Healthcare Businesswomen’s Association top honors for BD, GSK, Surgical Care Affiliates, and Walgreens Boots Alliance.
The Healthcare Businesswomen’s Association (HBA) will be recognizing BD (Becton, Dickinson and Company) GSK, Surgical Care Affiliates and Walgreens Boots Alliance as 2020 ACE Award winners for exemplary workplace initiatives that are working to close the gender and racial inequities in the healthcare and life sciences industry. The awards will be presented on Nov. 19.
HBA’s Advancement, Commitment and Engagement (ACE) Awards recognize companies committed to ensuring that gender diversity and leadership opportunities for women are part of their organizational DNA. An independent review panel of healthcare industry leaders selects ACE Award recipients for their excellence in advancing their female talent and removing the systemic barriers preventing timely progress to parity. Award criteria include measurable results, business performance, stewardship, execution, and sustainability.
The BD Women’s Initiative Network (WIN) earned recognition for re-thinking how mentoring programs can better drive career advancement and opportunities for all associates. GSK (GlaxoSmithKline) garnered honors for their Women’s Leadership Initiative (WLI), which embraces a culture of inclusion with women and men working side by side, and empowers women to realize their full potential without limitations.Surgical Care Affiliates (SCA) was selected as an award recipient for championing a Women’s Leadership Network that has resulted in significant growth in female leaders across the entire enterprise. Walgreens Boots Alliance has merited honors for its highly engaged Women of WBA business resource group (BRG). Initially established as a U.S. group, the BRG has evolved into a global network focused on increasing representation of women and People of Color across the company.
Throughout the year, the honorees’ programs are showcased across the HBA’s extensive community of healthcare and life science companies and are sought out by their peers for insights. A list of previous ACE awards recipients can be found here.
For more information on this year’s recipients, click here.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Phase III Trials Show Povorcitinib Significantly Improves Hidradenitis Suppurativa Outcomes
March 19th 2025In the Phase III STOP-HS1 and STOP-HS2 trials, results show that patients treated with povorcitinib for hidradenitis suppurativa experienced a ≥50% reduction in the total abscess and inflammatory nodule count.
